DUBLIN, Apr. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and white blood cells. Researchers have discovered that stem cells can be used for the treatment of 80 different diseases including thalassemia, sickle cell anemia, leukemia diabetes and cardiac diseases. The major sources for stem cell banking are storing of peripheral blood and bone marrow, umbilical cord blood (UCB) is by far considered as the largest component for hematopoietic stem cells.
Donated cord blood has become one of the most reliable sources for stem cells over the last decade and is thus considered as a valuable biological resource. The chances of cord blood sample matching with the patients that is closely in relation to the baby whose sample is to be used are 39% more than the sample obtained from the public banks. Cord blood banking services is a promising and a fast growing segment in the field of next generation stem cell therapy and national cord blood registries are changing perception and look of the industry.
Cord blood can be stored in either of the two ways, banking in private cord blood banks or donating in public cord blood banks. Private cord blood banks collect and store cord blood for the use of baby and close family members only. Collection and storage of the cord blood is charged to the parents of the baby. And secondly the cord blood can be donated to a public bank where the cord blood unit is stored and is publicly available for the suitable match. All the charges of storage and maintenance of the cord blood unit obtained from public bank are taken from the patient or patient's family for whom the unit is going to utilize in transplantation process. Though globally the number of private cord blood banks are more as compared to public banks, number of units stored in public banks are more than units of cord blood banks stored in private banks globally.
The amount of stem cells required for the transplantation process vary depending on person's weight and age. The major disadvantage of cord blood storing in private cord blood bank is that the single unit of the cord blood contains insufficient amount of stem cells and becomes difficult to treat adults using stem cell transplant. On the other hand, cord blood units stored in public banks is available to any patient matching with the blood unit sample stored in public banks globally.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Cord Blood Banking Services Market Overview
Chapter 4 Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion)
Chapter 5 Global Cord Blood Banking Services Market, by Geography, Size and Forecast, 2011 - 2019 (USD Billion)
Chapter 6 Recommendations
Chapter 7 Company Profiles
- China Cord Blood Corporation
- Cord Blood America, Inc.
- Cord Blood Registry Systems, Inc.
- Cordlife Group Ltd.
- Cryo-Cell International, Inc.
- Cryo-Save Group AV
- NeoStem, Inc.
- ViaCord, Inc.
For more information visit http://www.researchandmarkets.com/research/qsm3wn/cord_blood
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets